Zahabia Adnan: Meta-Analysis Supports Rivaroxaban as an Effective Option for Cancer-Associated VTE
Zahabia Adnan, Research Executive at Student Research Form-SMC, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
“I’m pleased to share our recently published systematic review and meta-analysis, ‘Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism,’ in Clinical and Applied Thrombosis/Hemostasis.
Analyzing data from 25 studies and 19,153 patients, our findings indicate that rivaroxaban was associated with a significant reduction in both VTE recurrence and all-cause mortality compared to low molecular weight heparin in patients with cancer-associated thrombosis.
These results contribute to the evolving evidence on anticoagulant selection in oncology and highlight the need for continued large-scale trials.
I’m grateful for the invaluable contributions of my co-authors for making this project successful.
Hoping to work on more projects too.
Do give a read to it.”
Title: Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
Authors: Zahabia Adnan, Syed Ibad Hussain, Amna Amir Jalal, Ayesha Shaukat, Eisha Abid, Muhammad Burhan, Arsalan Ahmed, Eshal Saghir, Shaikh Muhammad Daniyal, Shanza Shakir, Abedin Samadi, Ahmed Asad Raza
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke
-
Nov 9, 2026, 12:40Dimpy Modi: Pilot Trial Protocol Investigates Liberal vs. Restrictive Red Blood Cell Transfusion in Leukemia